May 21, 2001
Electronic Transmittal
Securities and Exchange Commission
450 Fifth Street, NW
Washington, DC 20549
Re: Interneuron Pharmaceuticals, Inc.
Dear Sir or Madam:
On behalf of J. Morton Davis and D.H. Blair Investment Banking Corp.,
transmitted herewith is an amended Schedule 13D reporting changes in
beneficial ownership of the securities of the above-mentioned company.
Very truly yours,
/s/ David Selengut
David Selengut
DS:dv
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 23)
--------------------
Interneuron Pharmaceuticals, Inc.
-----------------------------------------------------
(Name of Issuer)
Common Stock, $.001 par value
--------------------------------------------------------
(Title of Class of Securities)
460573108
----------------------------------------------------------
(CUSIP Number)
David Selengut, Ellenoff, Grossman, Schole, & Cyruli, LLP
370 Lexington Avenue, New York, NY 10017 (212) 370-1300
------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
May 21, 2001
-----------------------------------------------------------
(Date of Event which Requires FIling of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(b) (3) or (4), check the following box [ ].
Check the following box if a fee is being paid with this statement [ ].(A fee
is not required only if the reporting person: (1) has a previous statement
on file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule 13d-1(a) for other parties to whom copies are
to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 4 pages
CUSIP No. 460573108 13D Page 2 of 4 Pages
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
J. Morton Davis
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------------------
4 Source of Funds
See Item #3 herein.
-------------------------------------------------------------------------------
5 Check Box if Disclosure of Legal Proceedings is required pursuant to
Items 2(d) or 2(e)
-------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 5,146,487
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH 0
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 5,146,487
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,146,487
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
12%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT
CUSIP No. 460573108 13D Page 3 of 4 Pages
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
D.H. Blair Investment Banking Corp.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
-------------------------------------------------------------------------------
4 Source of Funds
See Item #3 herein.
-------------------------------------------------------------------------------
5 Check Box if Disclosure of Legal Proceedings is required pursuant to
Items 2(d) or 2(e)
-------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 5,096,331
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH 0
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 5,096,331
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,096,331
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11.9%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
BD
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT
Page 4 of 4 Pages
J. Morton Davis and D.H. Blair Investment Banking Corp. ("Blair
Investment"), (together, the "Reporting Parties") hereby amend the
following in their statement on Schedule 13D relating to the common
stock, $.001 par value ("shares") of Interneuron Pharmaceuticals, Inc.
(the "Issuer") as follows:
Item 5. (a) is hereby amended in its entirety as follows:
As of May 21, 2001, Mr. Davis may be deemed to beneficially own
5,146,487 shares or 12% of the Issuer's shares issued and outstanding
as follows: (i) 50,156 shares owned directly by Mr. Davis and (ii)
5,096,331 shares owned by Blair Investment.
As of May 21, 2001, Blair Investment may be deemed to beneficially
own 5,096,331 sgares ir 11.9% of the Issuer's shares as indicated
in (ii) above.
This Amendment corrects certain information contained in Amendment
#22.
Item 5. (b) is hereby amended in its entirety as follows:
Mr. Davis has the sole power to vote or to direct the vote, to
dispose or to direct the disposition of those shares owned directly by
him and those owned by Blair Investment.
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, we
certify that the information set forth in this statement is true, complete
and correct.
/s/ J. Morton Davis
Date: May 21, 2001 ____________________________
New York, New York J. Morton Davis
D.H. BLAIR INVESTMENT BANKING CORP.
/s/ David Nachamie
Date: May 21, 2001 by_____________________________
New York, New York David Nachamie
Treasurer